Exhibit 10.2
五星体育直播 Laboratories India Private Limited
G-01, Prestige Loka
7/1, Brunton Road
Bangalore, 560 025
www.codexis.com
April 22, 2011
Mr. Ajit Kamath
Arch Pharmalabs Ltd.
H Wing, 4th Floor
Tex Centre
Off Saki Vihar Road
Chandivali, Mumbai – 400072
India
RE: Conversion of Exclusivity for Phenylephrine, under that certain Product Supply Agreement, effective as of February 16, 2010, between 五星体育直播 Laboratories India Private Limited (“五星体育直播 India”) and Arch Pharmalabs Limited (“Arch”) (such agreement, the “PSA”)
Dear Mr. Kamath:
Pursuant to that certain letter regarding the conversion of the exclusive relationship between Arch and 五星体育直播 (“五星体育直播”) with respect to phenylephrine to a Non-Exclusive Relationship, effective as of April 22, 2011, between 五星体育直播 and Arch (the “Letter”), Arch is permitted to sell phenylephrine and CDX-004, which is used in the manufacture of phenylephrine and its intermediates (collectively, the “Phenylephrine Products”) to any Third Party. Notwithstanding anything to the contrary in the PSA, in conjunction with such conversion and subject to the terms and conditions of the Letter, 五星体育直播 India hereby consents to allow Arch to sell Phenylephrine Products to Third Parties and Arch hereby consents to allow 五星体育直播 India to sell Phenylephrine Products to Third Parties. The terms of this letter agreement shall become effective as of April 22, 2011.
Defined terms used herein but not defined herein have the meanings ascribed to them in the Letter. If you have any questions, please contact Peter Seufer-Wasserthal by telephone (+43 7673 321 511) or email (peter.seufer@codexis.com). For clarity, nothing in this letter shall be deemed to amend, modify, or supersede the terms agreed to in the PSA with respect to any Product other than the Phenylephrine Products.
Please indicate Arch’s agreement to the above by countersigning each enclosed duplicate of this letter and return one (1) original to the following address:
五星体育直播
Attn: Contracts
200 Penobscot Drive
Redwood City, CA 94063
| Best regards, | ||
| 五星体育直播 Laboratories India Private Limited | ||
| By: | /s/ Douglas Sheehy | |
| Name: | Douglas Sheehy | |
| Title: | Director | |
| Acknowledged, agreed and accepted by: | ||
| Arch Pharmalabs, Ltd. | ||
| Signature: | /s/ Ajit Kamath | |
| Print Name: | Ajit Kamath | |
| Date: | Chairman & Managing Director | |
Bringing Life to Chemistry™